Aft Pharmaceuticals

(ASX) AFP

Current Price$3.19

Market Cap$287.33M

Since IPO (2016)+10%

5 Year-22%

1 Year+37%

1 Month+17%

Aft Pharmaceuticals Financials at a Glance

Market Cap

$287.33M

Revenue (TTM)

$433.83M

Net Income (TTM)

$29.03M

EPS (TTM)

$0.15

P/E Ratio

18.15

Dividend

$0.02

Beta (Volatility)

-0.13 (Low)

Dividend

$0.02

Beta (Volatility)

-0.13 (Low)

Price

$3.19

Volume

Open

$3.19

Price

$3.19

Volume

Open

$3.19

Previous Close

$3.19

Daily Range

$3.19 - $3.19

52-Week Range

$2.20 - $3.37

Dividend

$0.02

Beta (Volatility)

-0.13 (Low)

Price

$3.19

Volume

Open

$3.19

Previous Close

$3.19

Daily Range

$3.19 - $3.19

52-Week Range

$2.20 - $3.37

AFP News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Aft Pharmaceuticals

Industry

Pharmaceuticals

Sector

Health Care

Employees

119

CEO

Hartley Atkinson, PhD

Website

www.aftpharm.com

Headquarters

Auckland, 0622, NZ

AFP Financials

Key Financial Metrics (TTM)

Gross Margin

45%

Operating Margin

11%

Net Income Margin

Return on Equity

19%

Return on Capital

25%

Return on Assets

10%

Earnings Yield

5.51%

Dividend Yield

0.61%

Payout Ratio

10.82%

Stock Overview

Market Cap

$287.33M

Shares Outstanding

104.87M

Volume

Avg. Volume

917.419

Financials (TTM)

Gross Profit

$89.19M

Operating Income

$11.70M

EBITDA

$21.52M

Operating Cash Flow

$13.18M

Capital Expenditure

$6.95M

Free Cash Flow

$6.22M

Cash & ST Invst.

$11.11M

Total Debt

$30.00M

Aft Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

$114.02M

+36.4%

Gross Profit

$49.29M

+37.2%

Gross Margin

43.23%

N/A

Market Cap

$287.33M

N/A

Market Cap/Employee

$2.61M

N/A

Employees

110

N/A

Net Income

$3.27M

+80.1%

EBITDA

$7.13M

+91.0%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Net Cash

$25.47M

+25.2%

Accounts Receivable

$36.65M

+9.7%

Inventory

$57.38M

+5.0%

Long Term Debt

$2.85M

-92.2%

Short Term Debt

$34.72M

+868.4%

Return on Assets

10.17%

N/A

Return on Invested Capital

24.61%

N/A

Free Cash Flow

$672.53K

-109.1%

Operating Cash Flow

$609.04K

-108.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

MVF.AXMonash IVF Group Limited

MVF.AXMonash IVF Group Limited$0.74+1.37%

AVR.AXAnteris Technologies Ltd

AVR.AXAnteris Technologies Ltd$8.13+5.52%

TTX.AXTetratherix Ltd.

TTX.AXTetratherix Ltd.$4.80+1.69%

MYX.AXMayne Pharma Group Limited

MYX.AXMayne Pharma Group Limited$2.81-1.06%

ARX.AXAroa Biosurgery Limited

ARX.AXAroa Biosurgery Limited$0.61-3.17%

OCC.AXOrthocell Limited

OCC.AXOrthocell Limited$0.91+1.68%

VLS.AXVita Life Sciences Limited

VLS.AXVita Life Sciences Limited$2.53+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

INTCIntel

INTCIntel$94.48-0.00%

NOKNokia

NOKNokia$12.91+0.04%

AMZNAmazon

AMZNAmazon$265.06+0.01%

SOFISoFi Technologies

SOFISoFi Technologies$16.10+0.04%

AAPLApple

AAPLApple$271.35+0.00%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.63+0.10%

MARAMara Holdings

MARAMara Holdings$11.99+0.12%

Questions About AFP

What is the current price of Aft Pharmaceuticals?

Aft Pharmaceuticals is trading at A$3.19 per share.

What is the 52-week range for Aft Pharmaceuticals?

Over the past 52 weeks, Aft Pharmaceuticals has traded between A$2.20 and A$3.37.

How much debt does Aft Pharmaceuticals have?

As of the most recent reporting period, Aft Pharmaceuticals reported total debt of $27.26M.

How much cash does Aft Pharmaceuticals have on hand?

Aft Pharmaceuticals reported $10.10M in cash and cash equivalents in its most recent financial results.

What is Aft Pharmaceuticals’s dividend yield?

Aft Pharmaceuticals currently has a dividend yield of 0.61%.

Aft Pharmaceuticals

Aft Pharmaceuticals Financials at a Glance

AFP News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Aft Pharmaceuticals

AFP Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Aft Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About AFP

What is the current price of Aft Pharmaceuticals?

What is the 52-week range for Aft Pharmaceuticals?

How much debt does Aft Pharmaceuticals have?

How much cash does Aft Pharmaceuticals have on hand?

What is Aft Pharmaceuticals’s dividend yield?

Premium Investing Services